Treatment of Relapsed/Refractory Pediatric Sarcomas With Gemcitabine and Docetaxel

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Oncology

• Publication date

  2009-05-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPH.0b013e3181b2598cPMID 27962455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hematopoietic stem cell transplantation in pediatric oncology.

  2009cited by this paper
• Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma

  2008cited by this paper
• Signature-Based Small Molecule Screening Identifies Cytosine Arabinoside as an EWS/FLI Modulator in Ewing Sarcoma

  2007cited by this paper
• Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].

  2007cited by this paper
• Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors

  2006cited by this paper
• Docetaxel and gemcitabine combination in 133 advanced soft‐tissue sarcomas: A retrospective analysis

  2006cited by this paper
• Survival after recurrence of Ewing's sarcoma family of tumors.

  2005cited by this paper
• Gemcitabine Radiosensitization after High-Dose Samarium for Osteoblastic Osteosarcoma

  2005cited by this paper
• Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors

  2004cited by this paper
• Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.

  2004cited by this paper
• Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma.

  2004cited by this paper
• The anti-angiogenic basis of metronomic chemotherapy

  2004cited by this paper
• High-dose therapy with autologous stem cell rescue for pediatric sarcomas

  2004cited by this paper
• Carboplatin‐based chemotherapy for refractory and recurrent Ewing's tumours

  2004cited by this paper
• Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines

  2003cited by this paper
• Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

  2002cited by this paper
• Survival after recurrence of Ewing Tumors

  2002cited by this paper
• Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

  2001cited by this paper
• Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial.

  1999cited by this paper
• Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial.

  1997cited by this paper
• Gemcitabine: current status of phase I and II trials.

  1994cited by this paper
• Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation.

  1992cited by this paper
• Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.

  1991cited by this paper

• Gemcitabine-docetaxel therapy in pediatric patients with relapsed or refractory sarcoma: a single-center experience

  2026influential citation
• Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, and Other Round Cell Sarcomas.

  2025cites this paper
• Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes

  2024cites this paper
• Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.

  2023cites this paper
• The O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status and clinical outcomes of Ewing sarcoma patients treated with irinotecan and temozolomide

  2022cites this paper
• Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives

  2021cites this paper
• Лечение рецидивов саркомы Юинга у детей и подростков: современный взгляд

  2021cites this paper
• Sarcomas of Bone and Soft Tissues in Children and Adolescents

  2021cites this paper
• A Pharmacological Analysis of the Activity and Failure of the Medical Treatment of High-Grade Osteosarcoma

  2021cites this paper
• Systemic Treatment of Ewing Sarcoma: Current Options and Future Perspectives

  2021cites this paper
• Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

  2021cites this paper
• OTT_A_193363 5093..5112

  2020cites this paper
• High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen

  2020cites this paper
• Contemporary Approach to Therapy for Ewing Sarcoma

  2020cites this paper
• Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation

  2020cites this paper
• Cutaneous reactions to pediatric cancer treatment: Part I. Conventional chemotherapy

  2020cites this paper
• Management of recurrent Ewing sarcoma: challenges and approaches

  2019cites this paper
• Gemcitabine/nab‐paclitaxel for pediatric relapsed/refractory sarcomas

  2018cites this paper
• Use of anlotinib in intra-abdominal desmoplastic small round cell tumors: a case report and literature review

  2018cites this paper
• Effective treatment of apatinib in desmoplastic small round cell tumor: a case report and literature review

  2018cites this paper
• Progress in the chemotherapeutic treatment of osteosarcoma.

  2018cites this paper
• Treatment pathway of bone sarcoma in children, adolescents, and young adults

  2017cites this paper
• Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.

  2017cites this paper
• Skin Tumors and Reactions to Cancer Therapy in Children

  2017cites this paper
• Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single‐center experience

  2017cites this paper
• Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina

  2016cites this paper
• Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma

  2016cites this paper
• Insulin-like Growth Factor Receptor Inhibition as Maintenance Therapy for Metastatic Ewing Sarcoma

  2016influential citation
• Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine‐Docetaxel Chemotherapy

  2016cites this paper
• Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma

  2016cites this paper
• Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma.

  2016cites this paper
• Systemic therapy for bone sarcomas

  2016cites this paper
• Metastatic extraskeletal Ewing's sarcoma treated with trabectedin: A case report

  2016cites this paper
• Innovative Exploratory Clinical Approaches for Relapsed and / or Refractory Metastatic Ewing ’ s Sarcoma

  2016cites this paper
• UK guidelines for the management of bone sarcomas

  2016cites this paper
• Osteosarcoma in Korean children and adolescents

  2015cites this paper
• Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.

  2015cites this paper
• Etoposide and carbo‐or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study

  2015cites this paper
• Ewing Sarcoma: Focus on Medical Management

  2015cites this paper
• Management of Ewing Sarcoma:Current Management and the Role of Radiation Therapy

  2015cites this paper
• Desmoplastic small round cell tumor 20 years after its discovery.

  2015cites this paper
• Pediatric primary splenic angiosarcoma: an aggressive multidisciplinary approach to the oncologic management of a rare malignancy

  2014cites this paper
• TL-118 and Gemcitabine Drug Combination Display Therapeutic Efficacy in a MYCN Amplified Orthotopic Neuroblastoma Murine Model – Evaluation by MRI

  2014cites this paper
• Ifosfamide-containing regimens for treating patients with osteosarcomas.

  2014cites this paper
• Gemcitabine and docetaxel for the treatment of children and adolescents with recurrent or refractory osteosarcoma: Korea Cancer Center Hospital experience

  2014cites this paper
• Docetaxel-associated palmar-plantar erythrodysesthesia: A case report and review of the literature

  2014cites this paper
• The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma

  2014cites this paper
• A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors

  2014influential citation
• miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells

  2014cites this paper
• Preclinical profile of cabazitaxel

  2014cites this paper
• Clinical Outcomes of Adult Patients With Relapsed Ewing Sarcoma: A 30-year Single-institution Experience

  2014cites this paper
• Gemcitabine for the treatment of patients with osteosarcoma.

  2014cites this paper
• Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute

  2014cites this paper
• Cyclophosphamide and Topotecan as First-line Salvage Therapy in Patients With Relapsed Ewing Sarcoma at a Single Institution

  2013cites this paper
• Optimal Management of Ewing Sarcoma Family of Tumors: Recent Developments in Systemic Therapy

  2013cites this paper
• Can taxanes provide benefit in patients with CNS tumors and in pediatric patients with tumors? An update on the preclinical development of cabazitaxel

  2013influential citation
• Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma

  2013cites this paper
• Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors

  2013cites this paper
• Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas

  2012cites this paper
• Gemcitabine, Docetaxel, and Bevacizumab in Relapsed and Refractory Pediatric Sarcomas

  2012cites this paper
• Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.

  2012cites this paper
• Recurrent Congenital Fibrosarcoma With Heart Metastases

  2012cites this paper
• Gemcitabine With or Without Docetaxel and Resection for Recurrent Osteosarcoma: The Experience at Children’s Memorial Hospital

  2012cites this paper
• Toxic erythema of chemotherapy with periorbital and perioral involvement.

  2012cites this paper
• La família de tumors del sarcoma d'Ewing

  2012cites this paper
• Integrating pharmacogenetics into gemcitabine dosing—time for a change?

  2011cites this paper
• Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future

  2011cites this paper
• Chimiothérapie de rattrapage par gemcitabine et docétaxel dans les sarcomes. Étude rétrospective monocentrique de 14 observations

  2011cites this paper
• Update on gemcitabine and docetaxel combination therapy for primary and metastatic sarcomas

  2010cites this paper
• diagnosed and recurrent ewing sarcoma in children and young adults

  2010cites this paper
• Current Therapeutic Approaches in Metastatic and Recurrent Ewing Sarcoma

  2010cites this paper
• Progress in the chemotherapeutic treatment of osteosarcoma ( Review )

  year unknowncites this paper